Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer (vol 6, pg 10604, 2015)

被引：0
|
作者：
Marin-Aguilera, Mercedes
Reig, Oscar
Lozano, Juan Jose
Jimenez, Natalia
Garcia-Recio, Susana
Erill, Nadina
Gaba, Lydia
Tagliapietra, Andrea
Ortega, Vanesa
Carrera, Gemma
Colomer, Anna
Gascon, Pedro
Mellado, Begona
机构：
来源：
ONCOTARGET | 2017年 / 8卷 / 16期
关键词：
D O I：
10.18632/oncotarget.17148
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：27673 / 27673
页数：1
相关论文
共 50 条
  • [21] High levels of circulating ceramides are associated with poor prognosis in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Cattrini, C.
    Manfredi, M.
    Barboro, P.
    Ghirimoldi, M.
    Mennitto, A.
    Martini, V.
    Battioni, A.
    Le Van, M.
    Biello, F.
    Platini, F.
    Ruffilli, B.
    Branni, C.
    Tassone, A.
    Gobbato, S.
    Stella, A.
    Catalano, F.
    Zanardi, E.
    Pinato, D. J.
    Boccardo, F.
    Gennari, A.
    ANNALS OF ONCOLOGY, 2022, 33 (08) : S1403 - S1404
  • [22] The use of circulating tumor cells in guiding treatment decisions for patients with metastatic castration-resistant prostate cancer
    Onstenk, Wendy
    de Kiaver, Willemijn
    de Wit, Ronald
    Lolkema, Martijn
    Foekens, John
    Sleijfer, Stefan
    CANCER TREATMENT REVIEWS, 2016, 46 : 42 - 50
  • [23] Prognosis of metastatic castration-resistant prostate cancer in response to chemotherapy and PSMA expression in circulating tumor cells
    Nagaya, N.
    Nagata, M.
    Ashizawa, T.
    Lu, Y.
    Fujita, K.
    Horie, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S1579 - S1580
  • [24] Predictive biomarkers in circulating tumor cells to direct management metastatic castration-resistant prostate cancer (mCRPC)
    Scher, Howard I.
    Schonhoft, Joseph
    Dittamore, Ryan
    CANCER RESEARCH, 2019, 79 (13)
  • [25] Molecular and genomic characterization of invasive circulating tumor cells (iCTCs) from men with metastatic castration-resistant prostate cancer (mCRPC).
    Friedlander, Terence W.
    Premasekharan, Gayatri
    Ngo, Vy
    Hang, Evelyn
    Graff, Julie Nicole
    Ryan, Charles J.
    Paris, Pamela
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] The End of the Beginning: Circulating Tumor Cells As a Biomarker in Castration-Resistant Prostate Cancer
    Friedlander, Terence W.
    Fong, Lawrence
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (11) : 1104 - +
  • [27] Molecular and genomic characterization of invasive circulating tumor cells (iCTCs) from men with metastatic castration-resistant prostate cancer (mCRPC)
    Friedlander, Terence W.
    Premasekharan, Gayatri
    Vy Ngo
    Doty, Shaun
    Harris, Anna
    Winter, Michael
    Gilbert, Elizabeth
    Craik, Charles
    Paris, Pamela
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [28] Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer
    McDaniel, Andrew S.
    Ferraldeschi, Roberta
    Krupa, Rachel
    Landers, Mark
    Graf, Ryon
    Louw, Jessica
    Jendrisak, Adam
    Bales, Natalee
    Marrinucci, Dena
    Zafeiriou, Zafeiris
    Flohr, Penelope
    Sideris, Spyridon
    Crespo, Mateus
    Figueiredo, Ines
    Mateo, Joaquin
    de Bono, Johann S.
    Dittamore, Ryan
    Tomlins, Scott A.
    Attard, Gerhardt
    BJU INTERNATIONAL, 2017, 120 (5B) : E30 - E44
  • [29] Luminal and basal subtyping of circulating tumor cells and influence on outcomes in patients with metastatic castration-resistant prostate cancer
    Wang, Jasmine Jiemei
    Kim, Minhyung
    Teng, Pai-Chi
    Jan, Yu Jen
    Chen, Jie-Fu
    Zhu, Yazhen
    You, Sungyong
    Tseng, Hsian-Rong
    Posadas, Edwin Melencio
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Risk Factors for Poor Survival in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel in Japan
    Yasuoka, Shotaro
    Yuasa, Takeshi
    Ogawa, Masahiro
    Komai, Yoshinobu
    Numao, Noboru
    Yamamoto, Shinya
    Kondo, Yukihiro
    Yonese, Junji
    ANTICANCER RESEARCH, 2019, 39 (10) : 5803 - 5809
12345